CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
NCT06420089
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
T Cell Non-Hodgkin Lymphoma
Interventions
DRUG:
Senza5 CART5
Sponsor
Vittoria Biotherapeutics
Collaborators
[object Object]